Health Officials Renew Indo-U.S. Vaccine Action Program
On May 3, 200, NIH and Indian officials signed a Joint Statement to renew the successful 20-year-old Indo-U.S. Vaccine Action program for another five years. (Standing from left) Dr. S Natesh, Adviser Scientist, Indian Department of Biotechnology; National Institutes of Health Director, Dr. Elias A. Zerhouni; National Institute of Allergy and Infectious Diseases Director, Dr. Anthony S. Fauci; Fogarty International Center Director, Dr. Roger I. Glass; Secretary of the Indian Department of Biotechnology, Dr. Maharaj K. Bhan; and Science and Technology Counselor from the Embassy of India, Dr. Kamal Kant Dwivedi.
Credit: Courtesy of Fogarty International Center